Home » Topics » BioWorld Science

BioWorld Science
RSS

C3aR is a potential therapeutic target in vascular cognitive impairment

April 7, 2021

Bile acid sequestrant SAR-442357 improves experimental type 2 diabetes and comorbidities

April 7, 2021

First subjects dosed in study comparing nasal nalmefene with nasal naloxone

April 6, 2021

Azafaros initiates phase I study of AZ-3102 for rare neurogenetic disorders

April 6, 2021

Molecular discontinues development of MT-3724 to focus on next-generation ETB candidates

April 6, 2021

FDA approves Qelbree for the treatment of ADHD in pediatric patients

April 6, 2021

Ionis initiates phase III study of ION-363

April 6, 2021

New nitazoxanide derivatives synthesized at Beijing Junke Huayuan Med Tech

April 6, 2021

Seven mostly unknown genes bring order to minimal genome cell division

April 6, 2021

BenevolentAI Bio patents tyrosine-protein kinase ABL1 inhibitors

April 6, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026